A detailed history of State Street Corp transactions in Sight Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 646,776 shares of SGHT stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
646,776
Previous 550,933 17.4%
Holding current value
$2.17 Million
Previous $3.67 Million 10.89%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.49 - $8.31 $526,178 - $796,455
95,843 Added 17.4%
646,776 $4.07 Million
Q2 2024

Aug 14, 2024

BUY
$5.13 - $7.15 $542,707 - $756,405
105,791 Added 23.77%
550,933 $3.67 Million
Q1 2024

May 15, 2024

BUY
$4.02 - $5.89 $14,061 - $20,603
3,498 Added 0.79%
445,142 $2.35 Million
Q4 2023

Feb 14, 2024

SELL
$1.29 - $5.86 $221,465 - $1.01 Million
-171,679 Reduced 27.99%
441,644 $2.28 Million
Q3 2023

Nov 14, 2023

BUY
$2.88 - $8.8 $10,823 - $33,070
3,758 Added 0.62%
613,323 $2.07 Million
Q2 2023

Aug 14, 2023

BUY
$7.46 - $10.67 $468,726 - $670,417
62,832 Added 11.49%
609,565 $5.05 Million
Q1 2023

May 15, 2023

BUY
$8.44 - $13.35 $380,137 - $601,284
45,040 Added 8.98%
546,733 $4.78 Million
Q4 2022

Feb 14, 2023

BUY
$5.58 - $13.94 $844,103 - $2.11 Million
151,273 Added 43.17%
501,693 $6.13 Million
Q3 2022

Nov 15, 2022

BUY
$6.1 - $11.41 $177,491 - $331,996
29,097 Added 9.06%
350,420 $2.23 Million
Q2 2022

Aug 15, 2022

SELL
$6.61 - $11.99 $1.65 Million - $2.99 Million
-249,483 Reduced 43.71%
321,323 $2.89 Million
Q1 2022

May 16, 2022

BUY
$11.56 - $17.9 $730,048 - $1.13 Million
63,153 Added 12.44%
570,806 $6.6 Million
Q4 2021

Feb 14, 2022

BUY
$17.36 - $27.36 $6.55 Million - $10.3 Million
377,569 Added 290.25%
507,653 $8.92 Million
Q3 2021

Nov 15, 2021

BUY
$22.34 - $39.1 $2.91 Million - $5.09 Million
130,084 New
130,084 $2.95 Million

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $161M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.